Cargando…
Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool
Statins are indicated for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Our previous study of 1042 consecutive patient encounters at our large urban academic institution found that one in five patients were not prescribed an appropriate statin therapy. Only one-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486342/ https://www.ncbi.nlm.nih.gov/pubmed/36113898 http://dx.doi.org/10.1136/bmjoq-2022-001947 |
_version_ | 1784792259243278336 |
---|---|
author | Rashid, Sana Suero-Abreu, Giselle Alexandra Tysarowski, Maciej Um, Hyo-bin Shah, Kajol Zhang, Yawen Douglas, Analise Matassa, Daniel |
author_facet | Rashid, Sana Suero-Abreu, Giselle Alexandra Tysarowski, Maciej Um, Hyo-bin Shah, Kajol Zhang, Yawen Douglas, Analise Matassa, Daniel |
author_sort | Rashid, Sana |
collection | PubMed |
description | Statins are indicated for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Our previous study of 1042 consecutive patient encounters at our large urban academic institution found that one in five patients were not prescribed an appropriate statin therapy. Only one-third of patients had follow-up cholesterol levels ordered to monitor treatment efficacy. In order to improve adherence to cholesterol guidelines at our institution, a quality improvement project was undertaken. We implemented interventions over a 4-month period to improve statin prescription rates: (a) development of an online interactive tool, (b) physician education on updated cholesterol guidelines and utilisation of the tool, (c) display of guideline summary in the workspace and (d) a documentation reminder in the electronic health record. We randomly selected encounter dates, from which 622 consecutive patient encounters were analysed. The primary outcome measures were prescription rates of statins, documentation of a 10-year ASCVD risk score and follow-up cholesterol levels ordered to monitor treatment efficacy. Out of the 622 patient encounters, 232 met statin indication. In this post-intervention group, statin prescription rates improved when compared with the pre-intervention group (90.5% vs 82.3%, p=0.006). Among patients who met statin indication solely via a 10-year ASCVD risk score ≥7.5%, there was an increase in documentation of the calculated 10-year ASCVD risk score (72.3% vs 57.8%; p=0.039) and in statin prescription rate (90.8% vs 67.6%; p<0.001). In addition, there was an increase in follow-up cholesterol levels ordered in all patients included in our study who met statin indication (64.1% vs 33.3%; p<0.001). Our quality improvement project showed higher rates of statin prescription, 10-year ASCVD risk score documentation and treatment monitoring after multiple interventions, centred on an easily accessible online interactive tool. |
format | Online Article Text |
id | pubmed-9486342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94863422022-09-21 Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool Rashid, Sana Suero-Abreu, Giselle Alexandra Tysarowski, Maciej Um, Hyo-bin Shah, Kajol Zhang, Yawen Douglas, Analise Matassa, Daniel BMJ Open Qual Quality Improvement Report Statins are indicated for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Our previous study of 1042 consecutive patient encounters at our large urban academic institution found that one in five patients were not prescribed an appropriate statin therapy. Only one-third of patients had follow-up cholesterol levels ordered to monitor treatment efficacy. In order to improve adherence to cholesterol guidelines at our institution, a quality improvement project was undertaken. We implemented interventions over a 4-month period to improve statin prescription rates: (a) development of an online interactive tool, (b) physician education on updated cholesterol guidelines and utilisation of the tool, (c) display of guideline summary in the workspace and (d) a documentation reminder in the electronic health record. We randomly selected encounter dates, from which 622 consecutive patient encounters were analysed. The primary outcome measures were prescription rates of statins, documentation of a 10-year ASCVD risk score and follow-up cholesterol levels ordered to monitor treatment efficacy. Out of the 622 patient encounters, 232 met statin indication. In this post-intervention group, statin prescription rates improved when compared with the pre-intervention group (90.5% vs 82.3%, p=0.006). Among patients who met statin indication solely via a 10-year ASCVD risk score ≥7.5%, there was an increase in documentation of the calculated 10-year ASCVD risk score (72.3% vs 57.8%; p=0.039) and in statin prescription rate (90.8% vs 67.6%; p<0.001). In addition, there was an increase in follow-up cholesterol levels ordered in all patients included in our study who met statin indication (64.1% vs 33.3%; p<0.001). Our quality improvement project showed higher rates of statin prescription, 10-year ASCVD risk score documentation and treatment monitoring after multiple interventions, centred on an easily accessible online interactive tool. BMJ Publishing Group 2022-09-15 /pmc/articles/PMC9486342/ /pubmed/36113898 http://dx.doi.org/10.1136/bmjoq-2022-001947 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Quality Improvement Report Rashid, Sana Suero-Abreu, Giselle Alexandra Tysarowski, Maciej Um, Hyo-bin Shah, Kajol Zhang, Yawen Douglas, Analise Matassa, Daniel Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title | Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title_full | Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title_fullStr | Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title_full_unstemmed | Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title_short | Increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
title_sort | increasing statin prescription rates to prevent cardiovascular disease among high-risk populations: a quality improvement intervention centred on a novel interactive tool |
topic | Quality Improvement Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486342/ https://www.ncbi.nlm.nih.gov/pubmed/36113898 http://dx.doi.org/10.1136/bmjoq-2022-001947 |
work_keys_str_mv | AT rashidsana increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT sueroabreugisellealexandra increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT tysarowskimaciej increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT umhyobin increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT shahkajol increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT zhangyawen increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT douglasanalise increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool AT matassadaniel increasingstatinprescriptionratestopreventcardiovasculardiseaseamonghighriskpopulationsaqualityimprovementinterventioncentredonanovelinteractivetool |